These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15915246)

  • 1. Demyelination-like syndrome in Crohn's disease after infliximab therapy.
    Freeman HJ; Flak B
    Can J Gastroenterol; 2005 May; 19(5):313-6. PubMed ID: 15915246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease.
    Thomas CW; Weinshenker BG; Sandborn WJ
    Inflamm Bowel Dis; 2004 Jan; 10(1):28-31. PubMed ID: 15058523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy.
    Dubcenco E; Ottaway CA; Chen DL; Baker JP
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):565-6. PubMed ID: 16607158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with infliximab in a patient with ankylosing spondylitis and Crohn's disease.
    Rednic S; Marinescu C; Chira R; Rogojan L; Rednic N
    J Gastrointestin Liver Dis; 2006 Dec; 15(4):379-82. PubMed ID: 17205151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of miliary tuberculosis under infliximab in a patient with spondyloarthritis and suspected Crohn's disease.
    Koschny R; Junghanss T; Mischnik A; Karner M; Kreuter M; Roth W; Stremmel W; Merle U
    Z Gastroenterol; 2013 Oct; 51(10):1177-83. PubMed ID: 24122379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of ankylosing spondylitis and Crohn's disease successfully treated with infliximab.
    Rebelo A; Leite S; Cotter J
    BioDrugs; 2010 Dec; 24 Suppl 1():37-9. PubMed ID: 21175236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy.
    Lozeron P; Denier C; Lacroix C; Adams D
    Arch Neurol; 2009 Apr; 66(4):490-7. PubMed ID: 19364934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease.
    Han PD; Cohen RD
    Drugs; 2004; 64(16):1767-77. PubMed ID: 15301561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eruptive benign melanocytic naevi during immunosuppressive therapy in a Crohn's disease patient.
    de Boer NK; Kuyvenhoven JP
    Inflamm Bowel Dis; 2011 Jun; 17(6):E26. PubMed ID: 21287668
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of infliximab in 10 years of clinical practice.
    O'Donnell S; Murphy S; Anwar MM; O'Sullivan M; Breslin N; O'Connor HJ; Ryan BM; O'Morain CA
    Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):603-6. PubMed ID: 21602689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients.
    Tanno M; Nakamura I; Kobayashi S; Kurihara K; Ito K
    Clin Rheumatol; 2006 Nov; 25(6):929-33. PubMed ID: 16328088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab, azathioprine, or combination therapy for Crohn's disease.
    Ruffolo C; Scarpa M; Bassi N
    N Engl J Med; 2010 Sep; 363(11):1086-7; author reply 1087-8. PubMed ID: 20848681
    [No Abstract]   [Full Text] [Related]  

  • 13. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
    Seddik M; Meliez H; Seguy D; Viget N; Cortot A; Colombel JF
    Inflamm Bowel Dis; 2004 Jul; 10(4):436-7. PubMed ID: 15475754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lewis and Sumner syndrome following infliximab treatment in Crohn's disease: a report of 2 cases.
    Nancey S; Bouhour F; Boschetti G; Magnier C; Gonneau PM; Souquet JC; Kaiserlian D; Flourie B
    Inflamm Bowel Dis; 2010 Sep; 16(9):1450-3. PubMed ID: 20128005
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe Legionella pneumophila pneumonia following infliximab therapy in a patient with Crohn's disease.
    Beigel F; Jürgens M; Filik L; Bader L; Lück C; Göke B; Ochsenkühn T; Brand S; Seiderer J
    Inflamm Bowel Dis; 2009 Aug; 15(8):1240-4. PubMed ID: 19217020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab-induced demyelination causes visual disturbance mistaken for recurrence of HLA-B27-related uveitis.
    Papadia M; Herbort CP
    Ocul Immunol Inflamm; 2010 Dec; 18(6):482-4. PubMed ID: 20735341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab].
    Gutierrez M; Becciolini A; Bertolazzi C; Di Geso L; Tardella M; Ariani A; Filippucci E; Grassi W
    Reumatismo; 2010; 62(3):221-4. PubMed ID: 21052570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histoplasma epiglottitis in a patient with Crohn's disease maintained on infliximab, prednisone, and azathioprine.
    Abou Zahr A; Saad Aldin E; Yunyongying P
    Int J Infect Dis; 2013 Aug; 17(8):e650-2. PubMed ID: 23769453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
    Seddik M; Melliez H; Seguy D; Viget N; Cortot A; Colombel JF
    Inflamm Bowel Dis; 2005 Jun; 11(6):618-20. PubMed ID: 15905713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.